Navigation Links
BrightFocus Foundation announces $7.2 million in grants for Alzheimer's and vision disease research
Date:7/10/2013

Clarksburg, MDBrightFocus Foundation, a nonprofit organization that funds innovative, early-stage research on Alzheimer's disease and the vision diseases of glaucoma and macular degeneration, today announced grant awards totaling more than $7.2 million to 53 scientists in 16 states and four foreign countries.

The funded research projects reflect the full range of new tools and innovationsin imaging technology, gene therapy, and cell regenerationthat scientists are using to better understand how diseases of mind and sight develop. Study results could lead to new therapies to prevent or treat these diseases.

"Investment in research has advanced our understanding of Alzheimer's and vision diseases," said BrightFocus President and CEO, Stacy Pagos Haller. "Now, thanks to new developments in genetics, neurology and imaging, the potential for scientists to make groundbreaking research discoveries is taking off. BrightFocus Foundation is more committed than ever to making this cutting-edge research possible, particularly at a time when government research funding levels are stagnant."

BrightFocus has provided $130 million to date in research funding, awarding more than $26 million for research on diseases of mind and sight in the last four years alone. This year's grantees include researchers from across the U.S., as well as Australia, Great Britain, Ireland, and Israel.

Alzheimer's Disease Research

Alzheimer's is a devastating degenerative disease that irreversibly destroys memory and other brain function over time. BrightFocus-funded scientists are studying various ways in which the "memory pathways" in the brainthe systems by which brain cells communicatecan go awry in this disease.

Some researchers are investigating whether certain chemicals control the "switches" to these pathways; others are using highly refined brain imaging or magnetic brain stimulation techniques to learn more about pathways; and some are using cell-based therapies to try to restore the brain circuits made during memory formation. Still others are studying how problems with brain blood flow contribute to Alzheimer's disease.

Glaucoma Research

For all three diseases, scientists want to know how inflammation and the body's immune response system may be involved, making the body turn against healthy cells in the brain or eyes. Several glaucoma researchers are examining the mind-eye connection, and why changes in the brain may contribute to the development of glaucoma long before vision loss occurs. Early detection is particularly important for glaucoma: in the U.S., an estimated half of the three million people with glaucoma may not know they have the disease.

Macular Degeneration Research

New cell-based and gene-based therapies may help stop the nerve damage and the loss of the eye's retinal cells involved in macular degeneration. The latest cell regeneration techniques may allow scientists to restore damaged eye cells or generate new healthy ones. Researchers are also investigating the mysterious presence of micro RNAs, a large group of small molecules that may affect the functioning of the retina in macular degenerationas well as brain functions in Alzheimer's disease.


'/>"/>

Contact: Alice L. Kirkman
akirkman@brightfocus.org
301-556-9349
AHAF-American Health Assistance Foundation
Source:Eurekalert

Related biology news :

1. Kessler Foundation implements Ekso Bionics first commercial robotic exoskeleton
2. Renowned geneticist R. Rodney Howell receives ACMG Foundation Lifetime Achievement Award
3. John A. Kaufman named 2012 Dotter Lecturer by Society of Interventional Radiology Foundation
4. Genzyme/ACMG Foundation Genetics Training Award in Clinical Biochemical Genetics announced
5. 2012 ACMG Foundation/Signature Genomic Laboratories Travel Award winner announced
6. ASBMB wins National Science Foundation grant to enhance K-12 science education
7. UF receives $1 million from Keck Foundation to study mechanisms of inherited disease
8. Merkin Family Foundation to fund next generation of Broad Institute scientists
9. Michael J. Fox Foundation grant to Dr. Samuel Young will provide Parkinsons drug development tools
10. New York Stem Cell Foundation scientist grows bone from human embryonic stem cells
11. National Psoriasis Foundation awards more than $2 million for research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/29/2016)... Nearly one billion matches per second with DERMALOG,s high-speed AFIS    ... ... DERMALOG is Germany's largest Multi-Biometric supplier: The ... Identification Systems) ... Germany's largest Multi-Biometric supplier: The company's Fingerprint Identification System is part of ...
(Date:11/22/2016)... According to the new market research report "Biometric ... Signature, Voice), Multi-Factor), Component (Hardware and Software), Function (Contact and Non-contact), Application, ... is expected to grow from USD 10.74 Billion in 2015 to reach ... and 2022. Continue Reading ... ...
(Date:11/19/2016)... , Nov. 18, 2016 Securus Technologies, ... solutions for public safety, investigation, corrections and monitoring, announced ... smaller competitor, ICSolutions, to have an independent technology judge ... the most modern high tech/sophisticated telephone calling platform, and ... customers that they do most of what we do ...
Breaking Biology News(10 mins):
(Date:12/2/2016)... , ... December 01, 2016 , ... ... long-term client Nanowear on their recent FDA Class II 510(k) clearance for their ... significant hurdle in commercializing remote cardiac monitoring devices that rely on cloth-based nanosensors. ...
(Date:12/2/2016)... a world leader in rapid infectious disease tests, introduced the Company,s newest product, the ... (Photo: http://photos.prnewswire.com/prnh/20161201/444905 ) Continue Reading ... ... , , bioLytical was invited by the ... INSTI HIV Self Test to 350 pharmacy representatives in Nairobi ...
(Date:11/30/2016)... Biotest Pharmaceuticals Corporation (BPC), a leading manufacturer ... addition of its newest plasma collection center located at ... The 15,200 square foot state-of-the-art facility officially opened its ... the total number of BPC,s plasma collection centers to ... Chief Executive Officer said "We are pleased to become ...
(Date:11/30/2016)... November 2016   Merck , ein ... Unterzeichnung einer Reihe von Vereinbarungen mit Evotec ... AG Screeningleistungen für Mercks Palette genetischer Reagenzien ... auf diese Bibliotheken in Kombination mit Evotecs ... Weg zur Ermittlung und Erforschung neuer Arzneimitteltargets.    ...
Breaking Biology Technology: